Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC–MS/MS for therapeutic drug monitoring
Menghua Zhang(Soochow University), Liyan Miao(Soochow University), Zhiyao Chen(Heilongjiang University of Chinese Medicine), Xiaoxue Liu(Soochow University), Min Tao(Shanghai East Hospital), Lin Wang(Zhuzhou Central Hospital), Shenhao Jiang(Suzhou Vocational Health College)
Cited by 18
Related Papers
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
|Cancer Discovery|2012|313
The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice
|Journal of Clinical Investigation|2011|227
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
|Nature Communications|2018|193
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
|The Lancet Oncology|2020|193
Knowledge Guided Capsule Attention Network for Aspect-Based Sentiment Analysis
|IEEE/ACM Transactions on Audio Speech and Language Processing|2020|88